In facility A, numbers of adult breeding rodents in each room were estimated. Each room was treated as a discrete population. Hypergeometric probability equations were used to determine sample size, similar to a previous lymphocytic choreomeningitis virus (LCMV) investigation (1) .
Given the estimated range of adult rodents per room (1,500-15,000), a sample size of 110 animals was estimated to have a 96.5%-96.9% probability of detecting at least 1 antibodypositive animal if the overall seroprevalence was >3%. Systematic sampling was used to select at least 1 adult animal from each rack in the room, with varying pan locations within the rack.
Juvenile animals were not sampled.
Diagnostic Assays

ELISA
Human serum was tested for LCMV IgM and IgG by using in-house ELISA as described (2) .
Mouse and rat serum was tested with a modified LCMV IgG ELISA by using goat antimouse conjugate (Cat 31446, Pierce, Rockford, IL, USA) or antirat conjugate (Cat 14-16-06, Kirkegaard & Perry Laboratories, Gaithersburg, MD, USA).
RT-PCR and Virus Genome RNA Sequencing
Tissue specimens of mouse liver and spleen (≈100 mg) were collected in 500 μL of lysis binding The RT-PCR was done as described (1) (3), by using the arenavirus standard primer Are19c (CGCACAGTGGATCCTAGGC). Multiple sequence alignments and phylogenetic analysis were done using MEGA4 (4).
Virus Isolation
For all mice found to have virus RNA detected by RT-PCR, 100 mg of mixed spleen and liver tissues were ground manually in Hank's Balanced Salt Solution and centrifuged. 100 μL of the resulting tissue homogenate suspension was inoculated on confluent Vero E6 cells. Flasks were incubated at 37°C and monitored for cytopathic effects. On day 7, culture medium was changed and cells checked by immunofluorescence assay (IFA) for the presence of LCMV. Negative cultures were kept until day 14 for a final IFA before being discarded. Positive cultures were harvested and stored.
